Lumida
/OPCH
⌘K
Option Care Health Inc

Option Care Health Inc

OPCH
$23.48USD-0.63%-0.15 today

MARKET CAP

3.5B

P/E (TTM)

13.4x

FWD P/E

11.8x

DAY RANGE

$23 – $24

52W RANGE

$18
$37

AI Summary

Stalk
TrimMedium

OPCH is exhibiting a Stage 4 decline with a bearish medium-term bias and price consolidating around the 9/20/50 EMAs in an overbought range. Immediate sell timing is limited, so execution should be deferred, trimming into strength on rallies toward resistance zones aligned with EMAs.

  • Q2 revenue rose 2% YoY to $1.4B (7% QoQ) with high single-digit organic growth
  • Operating cash flow $184M and free cash flow $256M fund growth initiatives
  • Profitability pressured by negative profitability factors and margin stress
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$3.4B$3.9B$4.3B$5.0B$5.6B
YoY %+13.4%+14.7%+9.1%+16.2%+13.0%
P / Sales1.5x1.4x1.4x0.8x0.9x
EV / Sales1.9x1.7x1.8x1.1x1.3x
Gross Profit, Adj.$779.6M$866.9M$981.2M$1.0B$1.1B
YoY %+14.3%+11.2%+13.2%+3.2%+7.4%
Margin %22.7%22.0%22.8%20.3%19.3%
EV / Gross Profit8.5x7.8x7.8x5.5x6.5x
EBITDA, Adj.$274.8M$305.7M$376.8M$385.3M$408.6M
YoY %+45.7%+11.2%+23.3%+2.3%+6.0%
Margin %8.0%7.7%8.8%7.7%7.2%
EV / EBITDA24.2x22.3x20.3x14.6x17.4x
EBIT$190.8M$240.2M$314.6M$321.8M$337.9M
YoY %+72.3%+25.9%+31.0%+2.3%+5.0%
Margin %5.5%6.1%7.3%6.4%6.0%
EV / EBIT34.8x28.3x24.3x17.4x21.0x
Net Income$139.9M$150.6M$267.1M$211.8M$207.6M
YoY %+1832.3%+7.6%+77.4%-20.7%-2.0%
Net Margin4.1%3.8%6.2%4.2%3.7%
EPS (GAAP)$0.77$0.83$1.48$1.23$1.27
YoY %+2025.0%+7.8%+78.3%-16.9%+3.3%